1. Home
  2. BHR vs SAVA Comparison

BHR vs SAVA Comparison

Compare BHR & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BHR

Braemar Hotels & Resorts Inc.

HOLD

Current Price

$2.87

Market Cap

185.6M

Sector

Real Estate

ML Signal

HOLD

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.10

Market Cap

156.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHR
SAVA
Founded
2013
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.6M
156.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BHR
SAVA
Price
$2.87
$2.10
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
788.3K
993.1K
Earning Date
02-25-2026
11-12-2025
Dividend Yield
7.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$710,399,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.80
$1.15
52 Week High
$3.28
$4.98

Technical Indicators

Market Signals
Indicator
BHR
SAVA
Relative Strength Index (RSI) 55.20 35.79
Support Level $2.77 $1.96
Resistance Level $2.88 $2.16
Average True Range (ATR) 0.10 0.16
MACD -0.00 -0.03
Stochastic Oscillator 50.24 15.35

Price Performance

Historical Comparison
BHR
SAVA

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: